The list of "unusual" problems that AMRN has faced is not limited to the recent court decisions. This company has faced obstacle after obstacle year after year for as long as I've been an investor which is over 10 years. In retrospect it appears they never had a fighting chance to succeed with so much stacked against them.. Great drug but a horrible and stressful investment. I thought this could easily be a $75-$100/share or more. Now I realize i could have enjoyed losing my money more by burning it in a fire pit instead of buying this stock.
I just never had the comfort with all the intangibles outside the drugs efficacy. Kennedy was selling stock when others weren't. JZ was a car salesmen. FDA was slow or inconsistent. The DU debacle..the mineral oil ad naseum but I've never been on the ground floor with a better drug. Now I hope it gets the chance globally to minimize pain, suffering and death. I take vascepa so perhaps it's what the plan was along :)
News 
Market Data 
Discover 
